相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Low doses of PEG-coated gold nanoparticles sensitize solid tumors to cold plasma by blocking the PI3K/AKT-driven signaling axis to suppress cellular transformation by inhibiting growth and EMT
Nagendra Kumar Kaushik et al.
BIOMATERIALS (2016)
Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)
Junjeong Choi et al.
ONCOTARGET (2016)
TAM receptor tyrosine kinases: Expression, disease and oncogenesis in the central nervous system
Angela M. Pierce et al.
BRAIN RESEARCH (2014)
The role of Src family kinases in growth and migration of glioma stem cells
Xiaosi Han et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
MerTK inhibition is a novel therapeutic approach for glioblastoma multiforme
Kristina H. Knubel et al.
ONCOTARGET (2014)
The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer
Douglas K. Graham et al.
NATURE REVIEWS CANCER (2014)
MEK-1 activates C-Raf through a Ras-independent mechanism
Deborah T. Leicht et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Molecular Pathways: MERTK Signaling in Cancer
Christopher T. Cummings et al.
CLINICAL CANCER RESEARCH (2013)
MERTK receptor tyrosine kinase is a therapeutic target in melanoma
Jennifer Schlegel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Genetic Dissection of TAM Receptor-Ligand Interaction in Retinal Pigment Epithelial Cell Phagocytosis
Tal Burstyn-Cohen et al.
NEURON (2012)
Biology, genetics and imaging of glial cell tumours
C. Walker et al.
BRITISH JOURNAL OF RADIOLOGY (2011)
Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
Rachel Ma Linger et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Inhibition of Mer and Axl Receptor Tyrosine Kinases in Astrocytoma Cells Leads to Increased Apoptosis and Improved Chemosensitivity
Amy K. Keating et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
John F. de Groot et al.
NEURO-ONCOLOGY (2010)
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
A. Soeda et al.
ONCOGENE (2009)
STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
Maureen M. Sherry et al.
STEM CELLS (2009)
Stem cell-related Self-Renewal signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma
Anastasia Murat et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Immunobiology of the TAM receptors
Greg Lemke et al.
NATURE REVIEWS IMMUNOLOGY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells
YM Wu et al.
CANCER RESEARCH (2004)
Cancerous stem cells can arise from pediatric brain tumors
HD Hemmati et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity
EM Behrens et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family
QX Lu et al.
SCIENCE (2001)
An implantable guide-screw system for brain tumor studies in small animals
S Lal et al.
JOURNAL OF NEUROSURGERY (2000)